Catt: If that's successful, then it strips off the vessel patch and promotes bleeding and perhaps strokes.
All the mechanisms involved in the disease aren't clearly understood.
Until they are, it's all too easy to do more damage then good.
There are many other opportunities to successfully apply our platform however.
The thing is, we keep getting distracted and expending scarce resources when we need to be focused on advancing our lead products through phase 3 and the FDA approval and marketing.
Unless we pull that off soon, we will be a helpless, desperate, cash flow negative, aging and outdated mini-biotech.
SOON!!
News 
Market Data 
Discover 
